A systematic cost-effectiveness analysis of pregabalin in the management of fibromyalgia: an Iranian experience (Q37517925)

20 August 2017

A systematic cost-effectiveness analysis of pregabalin in the management of fibromyalgia: an Iranian experience (English)

1 reference

cost-effectiveness analysis

20 August 2017

0 references

1 reference

Khosro Keshavarz

1

0 references

Mohammad Abdollahi

object named as

Mohammad Abdollahi

6

0 references

author name string

Amir Hashemi-Meshkini

2

1 reference

20 August 2017

Zahra Gharibnaseri

3

1 reference

20 August 2017

Shekoufeh Nikfar

4

1 reference

20 August 2017

Abbas Kebriaeezadeh

5

1 reference

20 August 2017

26 December 2013

1 reference

Archives of Medical Science

20 August 2017

1 reference

20 August 2017

9

1 reference

20 August 2017

961-967

1 reference

20 August 2017

6

1 reference

A model for developing a decision support system to simulate national drug policy indicators

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3902716

Cost effectiveness of pregabalin in the treatment of fibromyalgia from a UK perspective

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3902716

Societal and patient burden of fibromyalgia syndrome

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3902716

Fibromyalgia syndrome: presentation, diagnosis, differential diagnosis, and vulnerability.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3902716

Biology and therapy of fibromyalgia. New therapies in fibromyalgia

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3902716

Monitoring of National Drug Policy (NDP) and its standardized indicators; conformity to decisions of the national drug selecting committee in Iran

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3902716

A review of recent clinical trials of the nutritional supplement Chlorella pyrenoidosa in the treatment of fibromyalgia, hypertension, and ulcerative colitis.

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3902716

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3902716

The cost-effectiveness of pregabalin in the treatment of fibromyalgia: US perspective

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3902716

An international, randomized, double-blind, placebo-controlled, phase III trial of pregabalin monotherapy in treatment of patients with fibromyalgia

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3902716

A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3902716

The prevalence and characteristics of fibromyalgia in the general population.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3902716

Prevalence of fibromyalgia: a survey in five European countries

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3902716

A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3902716

Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3902716

Assessment of anxiety and quality of life in fibromyalgia patients.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3902716

Quality of life issues for fibromyalgia patients.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3902716

Evaluation of availability, accessibility and prescribing pattern of medicines in the Islamic Republic of Iran

2 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24482637

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Health services costs and their determinants in women with fibromyalgia

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24482637

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Fibromyalgia and quality of life: a comparative analysis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24482637

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.5114/AOMS.2013.39617

1 reference

20 August 2017

1 reference

20 August 2017

1 reference